Atheln is an innovative biopharma consulting group specializing in the creation of product development and commercial strategies. Our approach is unique in its integration of commercial and technical disciplines to maximize product value, relentless focus on identifying the key disciplines addressing client needs, exclusively utilizing industry seasoned experts, and being solely driven by client success. This approach is rooted in our extensive hands-on experience spanning from early research to life cycle management. The Atheln team has over 85 experts located in the US and EU with 20 - 45 years of global strategic and operational experience in Fortune 500 and start-up companies. Specialized teams are created for each project to address the specific needs of the client for single and/or multi-competency projects, interim, long-term or project based needs. In twelve years, Atheln has built up a top notch consulting practice and worked with over 90 companies in the US and Europe. Type of Products Biologics (cell therapies, gene therapies, recombinant fusion, transgenic proteins, MAbs, vaccines, biosimilars), small molecules, combination products, medical devices Therapeutic Areas Addiction, aesthetics, autoimmune disease, bone disease, cardiovascular, CNS, dermatology, endocrinology, gastroenterology, hematology, infectious diseases, inflammation, nephrology, oncology, ophthalmology, pain, psychiatry, transplantation, and urology